|
Dr. Johnson joined Kereos as a Director in September of 2005 bringing with him over two decades of venture capital experience. Prior to joining Prolog, he was Vice President of Monsanto Venture Capital and Monsanto’s director of new ventures and technology where he oversaw Monsanto’s $80 million portfolio of corporate venture investments. Dr. Johnson also spent 14 years as a general partner at Gateway Associates, a St. Louis-based venture capital company with more than $180 million in total funds under management. Besides Kereos, he also sits on the Boards of Everest, Singulex, and Stereotaxis. Dr Johnson holds a doctoral degree in physics from the University of Rochester and a bachelor’s degree from MIT. | 